Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cathepsin C | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | cathepsin C | 141 aa | 152 aa | 22.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.023 | 0.2558 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.023 | 0.2558 | 1 |
Echinococcus granulosus | a disintegrin and metalloproteinase with | 0.0147 | 0.1402 | 0.1354 |
Brugia malayi | hypothetical protein | 0.0068 | 0.0302 | 0.1323 |
Loa Loa (eye worm) | hypothetical protein | 0.0457 | 0.5719 | 1 |
Echinococcus multilocularis | adam | 0.0068 | 0.0302 | 0.0249 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0056 | 0.0134 | 0.0504 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0131 | 0.1176 | 0.1127 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.023 | 0.2558 | 0.2516 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.1176 | 0.2056 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0056 | 0.0134 | 0.5 |
Echinococcus granulosus | Blood coagulation inhibitor Disintegrin | 0.0136 | 0.1251 | 0.1203 |
Schistosoma mansoni | adam (A disintegrin and metalloprotease | 0.0068 | 0.0302 | 0.0249 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0764 | 1 | 1 |
Echinococcus granulosus | adam 17 protease | 0.0239 | 0.2683 | 0.2642 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0143 | 0.134 | 0.5 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0253 | 0.2874 | 0.2834 |
Brugia malayi | Hemopexin family protein | 0.0066 | 0.0262 | 0.1129 |
Schistosoma mansoni | ADAM17 peptidase (M12 family) | 0.0217 | 0.238 | 0.2338 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0253 | 0.2874 | 0.2834 |
Brugia malayi | metalloprotease disintegrin 16 with thrombospondin type I motif | 0.0103 | 0.078 | 0.3645 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0764 | 1 | 1 |
Echinococcus granulosus | adam | 0.0068 | 0.0302 | 0.0249 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.023 | 0.2558 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.023 | 0.2558 | 1 |
Brugia malayi | ADAM-TS Spacer 1 family protein | 0.0123 | 0.1061 | 0.5006 |
Mycobacterium ulcerans | hydrolase | 0.0056 | 0.0134 | 0.5 |
Schistosoma mansoni | ADAMTS5 peptidase (M12 family) | 0.0147 | 0.1402 | 0.1354 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.0262 | 0.0209 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.1061 | 0.1855 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.023 | 0.2558 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0134 | 0.0234 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0056 | 0.0134 | 0.5 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0103 | 0.0778 | 0.3035 |
Toxoplasma gondii | cathepsin CPC1 | 0.023 | 0.2558 | 1 |
Echinococcus multilocularis | a disintegrin and metalloproteinase with | 0.0147 | 0.1402 | 0.1354 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0051 | 0.0055 | 0.0096 |
Echinococcus multilocularis | adam 17 protease | 0.0217 | 0.238 | 0.2338 |
Echinococcus multilocularis | Blood coagulation inhibitor, Disintegrin | 0.0136 | 0.1251 | 0.1203 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0051 | 0.0055 | 0.0122 |
Loa Loa (eye worm) | matrixin family protein | 0.0103 | 0.0778 | 0.136 |
Onchocerca volvulus | Matrilysin homolog | 0.0187 | 0.196 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0197 | 0.2089 | 0.3653 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.023 | 0.2558 | 1 |
Brugia malayi | Matrixin family protein | 0.0197 | 0.2089 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.